PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Nucl Med Biol. 2011 Feb;38(2):247-53. doi: 10.1016/j.nucmedbio.2010.08.001.
Fatty acid amide hydrolase (FAAH) is the enzyme responsible for metabolising the endogenous cannabinoid, anandamide, and thus represents an important target for molecular imaging. To date, no radiotracer has been shown to be useful for imaging of FAAH using either positron emission tomography (PET) or single photon emission computed tomography (SPECT). We here determine the suitability of a novel carbon-11-labeled inhibitor of FAAH via ex vivo biodistribution studies in rat brain in conjunction with pharmacological challenges.
A potent irreversible inhibitor of FAAH, URB694, radiolabeled with carbon-11 in the carbonyl position ([(11)C]CURB), was administered to male rats via tail-vein injection. Rats were sacrificed at various time points postinjection, and tissue samples were dissected, counted and weighed. Specific binding to FAAH was investigated by pretreatment of animals with URB694 or URB597. For metabolism and mechanism of binding studies, whole brains were excised post-radiotracer injection, homogenised and extracted exhaustively with 80% aq. acetonitrile to determine the time course and fraction of radioactivity that was irreversibly bound to brain parenchyma.
Upon intravenous injection into rats, [(11)C]CURB showed high brain uptake [standard uptake value (SUV) of 1.6-2.4 at 5 min] with little washout over time, which is characteristic of irreversible binding. Highest uptake of radioactivity was seen in the cortex, intermediate in the cerebellum and lowest in the hypothalamus, reflecting the reported distribution of FAAH. Brain uptake of radioactivity was decreased in a dose-dependent manner by pretreatment with increasing amounts of URB694, demonstrating that binding was saturable. Pretreatment with the well-characterised FAAH inhibitor, URB597, reduced binding in all brain regions by 70-80%. Homogenised brain extraction experiments demonstrated unequivocally that [(11)C]CURB was irreversibly bound to FAAH.
The title radiotracer demonstrates favourable properties such as good brain uptake, regional heterogeneity and specificity of binding based on ex vivo biodistribution studies in conscious rat brain. [(11)C]CURB represents a highly promising radiotracer for the imaging of FAAH using PET.
脂肪酸酰胺水解酶(FAAH)是负责代谢内源性大麻素——花生四烯酸乙醇胺的酶,因此是分子成像的重要靶点。迄今为止,还没有放射性示踪剂被证明可用于正电子发射断层扫描(PET)或单光子发射计算机断层扫描(SPECT)成像 FAAH。我们通过在清醒大鼠脑中进行的体外生物分布研究以及药理学挑战,来确定新型的 FAAH 的碳-11 标记抑制剂的适用性。
将 FAAH 的一种强有力的不可逆抑制剂 URB694 在羰基位置用碳-11 进行放射性标记([(11)C]CURB),通过尾静脉注射给予雄性大鼠。在注射后不同时间点处死大鼠,解剖、计数和称重组织样本。通过用 URB694 或 URB597 预处理动物来研究 FAAH 的特异性结合。对于代谢和结合机制研究,在放射性示踪剂注射后切除整个大脑,用 80%含水乙腈充分匀浆并提取,以确定放射性核素不可逆结合到脑实质的时间过程和分数。
静脉注射到大鼠体内后,[(11)C]CURB 显示出高脑摄取[5 分钟时标准摄取值(SUV)为 1.6-2.4],随时间推移洗脱很少,这是不可逆结合的特征。放射性核素摄取最高见于皮质,中间见于小脑,最低见于下丘脑,反映了 FAAH 的报道分布。脑摄取放射性核素随 URB694 预处理剂量的增加呈剂量依赖性降低,表明结合是饱和的。用已充分表征的 FAAH 抑制剂 URB597 预处理,可使所有脑区的结合减少 70-80%。匀浆脑提取实验明确证明[(11)C]CURB 不可逆地结合到 FAAH。
该标题示踪剂在清醒大鼠脑的体外生物分布研究中表现出良好的脑摄取、区域异质性和结合特异性等有利特性。[(11)C]CURB 代表了用于 FAAH 成像的 PET 非常有前途的放射性示踪剂。